Ferring Pharmaceuticals Ltd

The Courtyard, Waterside Drive, Langley, Berkshire, SL3 6EZ
Telephone: +44 (0)1753 214 800
Fax: +44 (0)1753 214 802
WWW: http://www.ferring.co.uk
Medical Information Direct Line: +44 (0)1753 214 845
Medical Information e-mail: medical@ferring.com
Medical Information Fax: +44 (0)1753 214 801
Summary of Product Characteristics last updated on the eMC: 13/11/2009
SPC DesmoMelt 120mcg and 240mcg oral lyophilisate

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 13/11/2009 and displayed until Current
Reasons for adding or updating:
  • Change to section 6. 3 - Shelf Life
Date of revision of text on the SPC:   16-Oct-2009
Legal Category:   POM
Black Triangle (CHM):   YES

Free-text change information supplied by the pharmaceutical company

6.3 Shelf-life has been changed from 24 months to 36 months.
Updated on 04/07/2008 and displayed until 13/11/2009
Reasons for adding or updating:
  • Change to section 4.8 - Undesirable Effects
Date of revision of text on the SPC:   16-May-2008
Legal Category:   POM
Black Triangle (CHM):   YES

Free-text change information supplied by the pharmaceutical company

Black triangle added.

In section 4.8 (undesirable effects), disorders including aggression in children.......has been added.
Updated on 17/07/2007 and displayed until 04/07/2008
Reasons for adding or updating:
  • Addition of joint SPC covering all presentations
Updated on 26/01/2006 and displayed until 17/07/2007
Reasons for adding or updating:
  • New SPC for new product

Active Ingredients/Generics

 
   desmopressin acetate


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk